Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy Volunteers

Completed · Phase 1 · Has a placebo group

Conditions studied: Nasolabial Folds, Lipoatrophy, Lipodystrophy

In brief

This Phase 1, randomized, placebo-controlled, double-blind, healthy volunteer study tested the safety, tolerability, and plasma pharmacokinetics of two different concentrations of TAT4 Gel administered once daily to 50 cm2 of skin for 14 days.

Key facts

Study ID

NCT02647853

Run by

Topokine Therapeutics, Inc.

People needed

16

Starts

2014-10-01

Expected to finish

2014-12-01

Last updated by the study team

2016-01-06

Who can join

Age: 40 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Men and women 40-70 years old
• Healthy volunteers
• Provision of informed consent

You may not qualify if…

• History of skin hypersensitivity
• Abnormality on screening assessments

Where it is running

• Topokine Clinical Site — Cypress, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.